nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—Haematochezia—Varenicline—nicotine dependence	0.0546	0.0546	CcSEcCtD
Rifaximin—Upset stomach—Varenicline—nicotine dependence	0.0336	0.0336	CcSEcCtD
Rifaximin—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.0326	0.0326	CcSEcCtD
Rifaximin—Laryngeal pain—Varenicline—nicotine dependence	0.0323	0.0323	CcSEcCtD
Rifaximin—Rhinorrhoea—Varenicline—nicotine dependence	0.0271	0.0271	CcSEcCtD
Rifaximin—Disturbance in attention—Varenicline—nicotine dependence	0.0254	0.0254	CcSEcCtD
Rifaximin—Abnormal dreams—Varenicline—nicotine dependence	0.0217	0.0217	CcSEcCtD
Rifaximin—Hyperkalaemia—Varenicline—nicotine dependence	0.0216	0.0216	CcSEcCtD
Rifaximin—Influenza like illness—Varenicline—nicotine dependence	0.0214	0.0214	CcSEcCtD
Rifaximin—Urine output increased—Varenicline—nicotine dependence	0.0199	0.0199	CcSEcCtD
Rifaximin—Polyuria—Varenicline—nicotine dependence	0.0182	0.0182	CcSEcCtD
Rifaximin—Hot flush—Varenicline—nicotine dependence	0.0171	0.0171	CcSEcCtD
Rifaximin—Amnesia—Varenicline—nicotine dependence	0.017	0.017	CcSEcCtD
Rifaximin—Menopausal symptoms—Varenicline—nicotine dependence	0.0169	0.0169	CcSEcCtD
Rifaximin—Hypoglycaemia—Varenicline—nicotine dependence	0.0164	0.0164	CcSEcCtD
Rifaximin—Migraine—Varenicline—nicotine dependence	0.0157	0.0157	CcSEcCtD
Rifaximin—Abdominal pain upper—Varenicline—nicotine dependence	0.0146	0.0146	CcSEcCtD
Rifaximin—Nasopharyngitis—Varenicline—nicotine dependence	0.0143	0.0143	CcSEcCtD
Rifaximin—Abdominal distension—Varenicline—nicotine dependence	0.0139	0.0139	CcSEcCtD
Rifaximin—Dysphagia—Varenicline—nicotine dependence	0.0138	0.0138	CcSEcCtD
Rifaximin—Abdominal discomfort—Varenicline—nicotine dependence	0.0132	0.0132	CcSEcCtD
Rifaximin—Pollakiuria—Varenicline—nicotine dependence	0.0127	0.0127	CcSEcCtD
Rifaximin—Photosensitivity reaction—Varenicline—nicotine dependence	0.0126	0.0126	CcSEcCtD
Rifaximin—Weight increased—Varenicline—nicotine dependence	0.0126	0.0126	CcSEcCtD
Rifaximin—Hyperglycaemia—Varenicline—nicotine dependence	0.0124	0.0124	CcSEcCtD
Rifaximin—Infestation NOS—Varenicline—nicotine dependence	0.0123	0.0123	CcSEcCtD
Rifaximin—Infestation—Varenicline—nicotine dependence	0.0123	0.0123	CcSEcCtD
Rifaximin—Depression—Varenicline—nicotine dependence	0.0123	0.0123	CcSEcCtD
Rifaximin—Epistaxis—Varenicline—nicotine dependence	0.0116	0.0116	CcSEcCtD
Rifaximin—Hypoaesthesia—Varenicline—nicotine dependence	0.011	0.011	CcSEcCtD
Rifaximin—Urinary tract disorder—Varenicline—nicotine dependence	0.0109	0.0109	CcSEcCtD
Rifaximin—Oedema peripheral—Varenicline—nicotine dependence	0.0109	0.0109	CcSEcCtD
Rifaximin—Urethral disorder—Varenicline—nicotine dependence	0.0108	0.0108	CcSEcCtD
Rifaximin—Tinnitus—Varenicline—nicotine dependence	0.0103	0.0103	CcSEcCtD
Rifaximin—Angiopathy—Varenicline—nicotine dependence	0.01	0.01	CcSEcCtD
Rifaximin—Mediastinal disorder—Varenicline—nicotine dependence	0.00995	0.00995	CcSEcCtD
Rifaximin—Mental disorder—Varenicline—nicotine dependence	0.00967	0.00967	CcSEcCtD
Rifaximin—Malnutrition—Varenicline—nicotine dependence	0.00961	0.00961	CcSEcCtD
Rifaximin—Flatulence—Varenicline—nicotine dependence	0.00947	0.00947	CcSEcCtD
Rifaximin—Back pain—Varenicline—nicotine dependence	0.0093	0.0093	CcSEcCtD
Rifaximin—Muscle spasms—Varenicline—nicotine dependence	0.00924	0.00924	CcSEcCtD
Rifaximin—Tremor—Varenicline—nicotine dependence	0.00901	0.00901	CcSEcCtD
Rifaximin—Ill-defined disorder—Varenicline—nicotine dependence	0.00892	0.00892	CcSEcCtD
Rifaximin—Anaemia—Varenicline—nicotine dependence	0.00889	0.00889	CcSEcCtD
Rifaximin—Angioedema—Varenicline—nicotine dependence	0.00878	0.00878	CcSEcCtD
Rifaximin—Malaise—Varenicline—nicotine dependence	0.00867	0.00867	CcSEcCtD
Rifaximin—Vertigo—Varenicline—nicotine dependence	0.00864	0.00864	CcSEcCtD
Rifaximin—Syncope—Varenicline—nicotine dependence	0.00862	0.00862	CcSEcCtD
Rifaximin—Loss of consciousness—Varenicline—nicotine dependence	0.00845	0.00845	CcSEcCtD
Rifaximin—Cough—Varenicline—nicotine dependence	0.00839	0.00839	CcSEcCtD
Rifaximin—Myalgia—Varenicline—nicotine dependence	0.00818	0.00818	CcSEcCtD
Rifaximin—Chest pain—Varenicline—nicotine dependence	0.00818	0.00818	CcSEcCtD
Rifaximin—Arthralgia—Varenicline—nicotine dependence	0.00818	0.00818	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00813	0.00813	CcSEcCtD
Rifaximin—Discomfort—Varenicline—nicotine dependence	0.00809	0.00809	CcSEcCtD
Rifaximin—Dry mouth—Varenicline—nicotine dependence	0.008	0.008	CcSEcCtD
Rifaximin—Infection—Varenicline—nicotine dependence	0.00779	0.00779	CcSEcCtD
Rifaximin—Shock—Varenicline—nicotine dependence	0.00772	0.00772	CcSEcCtD
Rifaximin—Nervous system disorder—Varenicline—nicotine dependence	0.00769	0.00769	CcSEcCtD
Rifaximin—Skin disorder—Varenicline—nicotine dependence	0.00762	0.00762	CcSEcCtD
Rifaximin—Hyperhidrosis—Varenicline—nicotine dependence	0.00758	0.00758	CcSEcCtD
Rifaximin—Anorexia—Varenicline—nicotine dependence	0.00748	0.00748	CcSEcCtD
Rifaximin—Hypotension—Varenicline—nicotine dependence	0.00733	0.00733	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00715	0.00715	CcSEcCtD
Rifaximin—Insomnia—Varenicline—nicotine dependence	0.0071	0.0071	CcSEcCtD
Rifaximin—Dyspnoea—Varenicline—nicotine dependence	0.00699	0.00699	CcSEcCtD
Rifaximin—Decreased appetite—Varenicline—nicotine dependence	0.00682	0.00682	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00677	0.00677	CcSEcCtD
Rifaximin—Fatigue—Varenicline—nicotine dependence	0.00676	0.00676	CcSEcCtD
Rifaximin—Pain—Varenicline—nicotine dependence	0.00671	0.00671	CcSEcCtD
Rifaximin—Constipation—Varenicline—nicotine dependence	0.00671	0.00671	CcSEcCtD
Rifaximin—Feeling abnormal—Varenicline—nicotine dependence	0.00647	0.00647	CcSEcCtD
Rifaximin—Gastrointestinal pain—Varenicline—nicotine dependence	0.00642	0.00642	CcSEcCtD
Rifaximin—Urticaria—Varenicline—nicotine dependence	0.00623	0.00623	CcSEcCtD
Rifaximin—Body temperature increased—Varenicline—nicotine dependence	0.0062	0.0062	CcSEcCtD
Rifaximin—Abdominal pain—Varenicline—nicotine dependence	0.0062	0.0062	CcSEcCtD
Rifaximin—Hypersensitivity—Varenicline—nicotine dependence	0.00578	0.00578	CcSEcCtD
Rifaximin—Asthenia—Varenicline—nicotine dependence	0.00563	0.00563	CcSEcCtD
Rifaximin—Pruritus—Varenicline—nicotine dependence	0.00555	0.00555	CcSEcCtD
Rifaximin—Diarrhoea—Varenicline—nicotine dependence	0.00537	0.00537	CcSEcCtD
Rifaximin—Dizziness—Varenicline—nicotine dependence	0.00519	0.00519	CcSEcCtD
Rifaximin—Vomiting—Varenicline—nicotine dependence	0.00499	0.00499	CcSEcCtD
Rifaximin—Rash—Varenicline—nicotine dependence	0.00495	0.00495	CcSEcCtD
Rifaximin—Dermatitis—Varenicline—nicotine dependence	0.00494	0.00494	CcSEcCtD
Rifaximin—Headache—Varenicline—nicotine dependence	0.00491	0.00491	CcSEcCtD
Rifaximin—Nausea—Varenicline—nicotine dependence	0.00466	0.00466	CcSEcCtD
